2015, Volume 9, Issue 3

Stały URI dla tej kolekcji

https://hdl.handle.net/20.500.13044/2157

Przeglądaj

Przeglądanie 2015, Volume 9, Issue 3 według Temat " hypertension"
  • Rekord
    Acceptance of illness and satisfaction with life among patients with arterial hypertension
    (Państwowa Szkoła Wyższa im. Papieża Jana Pawła II w Białej Podlaskiej, 2016-01-13) Baczewska, Bożena ; Kropornicka, Beata ; Sepioło, Joanna ; Krzyżanowska, Ewa ; Olszak, Cecylia ; Szymczuk, Ewa ; Daniluk, Jadwiga
    The aim of this study was to determine and compare the degree of acceptance of the disease and the level of satisfaction with life among people with diagnosed hypertension. The research was carried out by means of a diagnostic survey. The study used the scale of AIS - Approval Illness Scale (Acceptance of Illness Scale). For measuring life satisfaction ladder Cantrill was used. It assessed satisfaction with life on a scale from 0 to 10. The study was conducted in June 2014 among the residents of Lubelskie and Świętokrzyskie voivodships. The study was anonymous. The approval of the Bioethics Committee at the Medical University of Lublin (KE-0254/176/2014) was received for carrying out the tests. The study included patients diagnosed with hypertension – total of 154 people. The study has shown the average degree of acceptance of the disease. Illness and healing therapy did not impact negatively the functioning of most respondents. The respondents described their adaptation to the limitations imposed by the disease in different degrees. The vast majority of respondents did not have any problems arising from the disease and did not abandon their favorite activities. Every third respondent with hypertension felt as being a defective person and dependent on other people. The relation between satisfaction with their own lives, and the level of acceptance of the disease was concluded in that study. The higher the degree of satisfaction with patients’ lives, the higher the acceptance of illness. Studies have shown positive correlations between gender, age, place of residence, duration of illness and education, and acceptance of the disease. In contrast, there was no statistically significant association between marital status and the test subject.
  • Rekord
    New aspects in the treatment of hypertension
    (Państwowa Szkoła Wyższa im. Papieża Jana Pawła II w Białej Podlaskiej, 2016-01-13) Meretskyi, Viktor
    Hypertension is currently the leading cause of cardiovascular complications (heart attack, stroke) and the resulting deaths of patients. Reduced morbidity and mortality from cardiovascular complications is the main goal of treating patients suffering from high blood pressure (BP). To achieve target BP levels in the arsenal of physicians are five major classes of antihypertensive drugs: angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, β-blockers, diuretics. The choice of antihypertensive drug in concrete clinical situation often complicated and determined by complex factors. Among these presence of risk factors; target organ damage; associated clinical conditions, metabolic syndrome, diabetes, comorbidities; possible individual patient response to antihypertensive drugs of different classes in history; the likelihood of drug interactions; socio-economic factors, including the cost of treatment of hypertension. Promising is the use of angiotensin II receptor blockers ‑ drugs with pleiotropic pharmacological properties that have a multicomponent antihypertensive efficacy, good tolerability, diverse organoprotection that are safe, able to enhance remote prognosis for patients with hypertension. Azilsartan medoxomil is a competitive reversible angiotensin II type 1 receptor antagonist. Azilsartan developing hypotensive effect faster, prolonged and pronounced compared to other sartans (valsartan, candesartan and olmesartan). In addition to antihypertensive action azilsartan medoxomil shows a number of additional pleiotropic effects. These include antithrombotic, antiproliferative and antyfibrotic action. It demonstrates the improvement in glucose tolerance and tissue insulin sensitivity, improves endothelial function, reduces the progression of albuminuria, proteinuria.